BIO Will Have New President By End Of Year; Feldbaum Stepping Down

BIO President Carl Feldbaum is stepping down after 11 years. His successor will face emerging debate on "generic" biologics and implementation of the Medicare law.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet